Pharmacia & Upjohn

Farmitalia Carlo Erba S.r.l.

Luisa Garofano

Anna Luisa Colombo

Paolo Carminati

Marina Ciomei

Carlo Battistini

Domenico Ungheri

Umberto Breme

Giuliano Franchi

Francesca Torti

Marinella Caruso

Guy Mazue

Emanuele Arlandini

Cinzia Portello

Marco Tat&oacute;

Giuliano Oronzo

Guiseppe Zanella

Anthracycline glycosides

Doxorubicin resistance can be conferred on a host by transforming the host with a recombinant vector comprising a DNA having the configuration of restriction sites shown in FIGS. 1 or 2 of the accompanying drawings or a restriction fragment derived therefrom containing a gene coding for doxorubicin resistance.

Isolation and characterisation of genes resistant to anthracycline

A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharmaceutically acceptable carriers. The fibroblast growth factor may be a basic fibroblast growth factor or an analogue thereof, and the polysaccharide may be a carrageenan, heparin, dextran sulfate, pentosan polysulfate or a sulfated polysaccharides produced by marine algae belonging to the class of Rhodophyceae.

Synergistic composition comprising a fibroblast growth factor and a

Growing community of inventors

Monza, Italy

Luisa Garofano